Latham & Watkins represented TA Associates, a leading global private equity firm, in its investment in Diatech Pharmacogenetics, a leader in pharmacogenetics and cancer precision medicine diagnostics.
Upon completion of the transaction, TA Associates will start a strategic collaboration with Diatech’s management and founders, that will retain a majority interest in the company.
Latham & Watkins advised TA Associates on corporate matters with a team led by partners Stefano Sciolla and Giorgia Lugli, with Federica Ventura and Nicholas Luraghi. Partner Cesare Milani and Edoardo Cassinelli advised on the regulatory aspects of the deal.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
